Clinical trials
Active, not recruiting Polycythemia Vera trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2013 | 1 |
| 2015 | 2 |
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 20 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| City of Hope Medical Center | 2 |
| M.D. Anderson Cancer Center | 2 |
| Novartis Pharmaceuticals | 2 |
| PharmaEssentia | 2 |
| Protagonist Therapeutics, Inc. | 2 |
| AbbVie | 1 |
| Barbara Ann Karmanos Cancer Institute | 1 |
| Disc Medicine, Inc | 1 |
| IRCCS Azienda Ospedaliero-Universitaria di Bologna | 1 |
| Italfarmaco | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Polycythemia Vera | 20 |
| Thrombocythemia, Essential | 11 |
| Primary Myelofibrosis | 10 |
| Leukemia, Myeloid, Acute | 6 |
| Leukemia, Myelomonocytic, Chronic | 6 |
| Myeloproliferative Disorders | 6 |
| Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 5 |
| Leukemia, Neutrophilic, Chronic | 4 |
| Blast Crisis | 3 |
| Burkitt Lymphoma | 3 |
Trials
Showing 76 to 20 of 20. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.